Literature DB >> 1683927

Uveitis: pathogenesis.

J V Forrester1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1683927     DOI： 10.1016/0140-6736(91)92309-p

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  36 in total

1.  Diverse roles of natural killer T lymphocytes in liver and spleen in mice with experimental autoimmune uveitis.

Authors:  Shengya Zhao; Dadong Guo; Hongsheng Bi; Yan Cui; Xiaofeng Xie; Xingrong Wang; Jiao Li
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

Review 2.  FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh.

Authors:  A W Thomson; P B Carroll; J McCauley; J Woo; K Abu-Elmagd; T E Starzl; D H Van Thiel
Journal:  Springer Semin Immunopathol       Date:  1993

3.  Uveitogenic epitopes of retinal S-antigen are generated in vivo via an alternative antigen-presentation pathway.

Authors:  J Liversidge; R Dawson; A D Dick; J V Forrester
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

Review 4.  Uveitis in the elderly--is it easy to identify the masquerade?

Authors:  P Zamiri; S Boyd; S Lightman
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

Review 5.  Immunopathology of uveitis.

Authors:  C C Chan; Q Li
Journal:  Br J Ophthalmol       Date:  1998-01       Impact factor: 4.638

Review 6.  Chronic non-infectious uveitis in the elderly: epidemiology, pathophysiology and management.

Authors:  Rajen Gupta; Philip I Murray
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

7.  The pituitary-adrenal axis in idiopathic retinal vasculitis.

Authors:  H E Palmer; M R Stanford; C Lowy; M J Wheeler; G R Wallace; E M Graham
Journal:  Br J Ophthalmol       Date:  1999-12       Impact factor: 4.638

8.  Crucial role of P2X7 receptor for effector T cell activation in experimental autoimmune uveitis.

Authors:  Atsunobu Takeda; Hisakata Yamada; Eiichi Hasegawa; Mitsuru Arima; Shoji Notomi; Sayaka Myojin; Takeru Yoshimura; Toshio Hisatomi; Hiroshi Enaida; Ryoji Yanai; Kazuhiro Kimura; Tatsuro Ishibashi; Koh-Hei Sonoda
Journal:  Jpn J Ophthalmol       Date:  2018-03-23       Impact factor: 2.447

Review 9.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

10.  Toxoplasma serotype is associated with development of ocular toxoplasmosis.

Authors:  Leila Shobab; Uwe Pleyer; Joerdis Johnsen; Sylvia Metzner; Erick R James; N Torun; Michael P Fay; Oliver Liesenfeld; Michael E Grigg
Journal:  J Infect Dis       Date:  2013-07-21       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.